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Abstract
With technological advances in high-throughput genotyping, it is not unusual to perform hundreds
of thousands of tests for each phenotype. Thus, correction to control type I error is essential. The
false-discovery rate (FDR) has been successfully used in genome-wide expression data. However,
its performance has not been evaluated for association analysis. Our objective was to analyze the
Genetic Analysis Workshop 15 simulated data set, with answers, to evaluate FDR for genome-wide
association and fine mapping. In genome-wide analysis, FDR performed well, with good localization
of positive results. However, in fine mapping, all tested methods performed poorly, producing a
high proportion of significant results. Thus, caution should be used when employing FDR for fine
mapping.
Background
Multiple testing within research studies takes many forms,
including multiple comparisons regarding a single out-
come, multiple outcomes, or multiple secondary analyses.
Each scenario increases the overall probability of false-
positive outcomes. With technological advances in high-
throughput genotyping, it is not unusual to perform hun-
dreds of thousands of tests for each phenotype in genome-
wide association studies. Thus, strategies are required to
control type I error rate.
The false-discovery rate (FDR) was originally proposed by
Benjamini and Hochberg as a method to adjust for multi-
ple comparisons [1]. Less conservative than traditional
control of family-wise error (FWE) rate (likelihood of
making at least one type I error over all tests), FDR is the
expected proportion of 'significant' tests that are truly
null. FDR was extended by Storey with the q-value, the
FDR analogue of the p-value [2]. The q-value is the propor-
tion of significant single-nucleotide polymorphisms
(SNPs) that will be false positives for a given threshold.
For example, if we want to review SNPs with q-values ≤
0.05 and this yields 200 SNPs, then approximately 10 of
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these 'significant' SNPs are expected to be null. Storey
assumes that null p-values are uniformly distributed, and
can thus be used to determine the q-value. These assump-
tions are valid for genome-wide expression data [2]. How-
ever, performance of FDR in genome-wide association
studies has not been evaluated with simulated data.
In genome-wide linkage and association studies, it is com-
mon practice to follow up previously identified linkage
and association signals with dense genotyping in that area
(e.g., fine mapping). Genotyping a large number of SNPs
in a region may introduce non-independence due to link-
age disequilibrium (LD). Additionally, we would expect
an increase in the number of true positives, as these
regions were selected because of previous evidence of link-
age or association. Unfortunately, the impact of non-inde-
pendence and increased true positives on the distribution
of null p-values and FDR performance has not been
explored. Therefore, our objective was to analyze the
Genetic Analysis Workshop 15 (GAW15) simulated data
set, with answers, to evaluate FDR for genome-wide asso-
ciation and fine mapping.
Methods
Data
GAW15 simulated rheumatoid arthritis (RA) data consists
of 1500 families with an affected sibling pair and 2000
unaffected controls. The authors had knowledge of the
simulated answers at the time of analyses.
All 9187 SNPs on 22 autosomes were analyzed in 11 rep-
licates (90–100). The dense map of 17,820 SNPs on chro-
mosome 6 was used to further model an analysis of
follow-up of a known linkage peak region. Of these SNPs,
2094 within 10 cM flanking the causative allele at locus
DR, as provided in the answers, were selected for analysis.
Statistical analysis
CCREL in the computer program R [3] was used for SNP
association analysis. This package permits case-control
analysis controlling for familial relationships. Because the
GAW15 data provided information on family trios, as
well as controls, this was an optimal method for analysis.
p-values for each replicate were imported into QVALUE
and analyzed using default settings and a FDR of 0.05 [2].
To compare FDR performance in genome-wide versus fine
mapping, we compared the number of tests meeting this
FDR threshold for each replicate and the average esti-
mated π0 (the probability that a given hypothesis is truly
null). To compare methods, FDR was also estimated using
the method of Benjamini and Hochberg [1] and a robust
method assuming discrete p-values [4]. Results from FDR
were compared with a nominal p-value threshold of 0.05
and Bonferroni corrected thresholds of 0.05/9187 = 5*10-
6 for genome-wide and 0.05/2094 = 2*10-5 for fine map-
ping.
To examine the underlying assumption of a uniform dis-
tribution of p-values, we inspected the p-value distribution
from all replicates combined. To explore the empirical
false-positive (FP) rate, SNPs identified as significant in
the genome-wide association analysis were examined for
proximity to any of the modeled causative loci. Significant
SNPs within either 10 cM or 5 cM of causative loci were
labeled 'true positives' (TP), and the proportion of all sig-
nificant SNPs labeled 'true positive' and 'false positive'
(where FP = 1 - TP) was calculated.
Because non-independence could also influence the
results, we examined LD between the SNP at the DR locus
and 186 SNPs flanking DR. LD was calculated using r2.
Spearman's rank correlation between LD and p-values for
the association was used to determine if the p-values were
related to LD.
Results
Genome-wide association
An average of 5.5% of SNPs was significant at p ≤ 0.05
compared to 0.27% and 0.21% of SNPs using FDR and
Bonferroni adjustment, respectively. Estimated π0 aver-
aged 0.99 (Table 1). The plot of q-values against the corre-
sponding p-values exhibited exponential increases in q-
values associated with small increases in p-values close to
0 (Fig. 1A). The p-values appeared uniformly distributed
above p = 0.10, while the frequency at p ≤ 0.05 was only
slightly higher than baseline (Fig. 2A).
FP rates for significant SNPs differed greatly by method.
For the nominal p ≤ 0.05 threshold, 4920 of 5541 signifi-
cant SNPs (89%) were >10 cM and 5003 (90%) were >5
cM from a causative locus. Even on chromosomes with a
causative locus, the 5-cM FP rate was marginally lower on
only three of the six chromosomes (6 [52%], 11 [75%],
and 18 [77%]). Using FDR thresholds, only 9 of the 272
SNPs were >5 cM from a causative locus, for a 5-cM FP rate
of 3.3%, with the vast majority (96.3%) within 3 cM of a
causative locus. Bonferroni thresholds identified 217 sig-
nificant SNPs, all but one of which (0.46%) was within 3
cM of causative loci. Loci that mediated RA hazard or
increased RA severity were not identified using any
method.
Fine mapping
In contrast, using the dense chromosome 6 SNPs, an aver-
age of 45.2% of SNPs was significant at p ≤ 0.05 compared
with 46.4% and 21.4% of SNPs using FDR and Bonfer-
roni, respectively. A cluster of 186 significant SNPs
spanned 2 Mb around DR, but these accounted for less
than 20% of significant associations.BMC Proceedings 2007, 1(Suppl 1):S148 http://www.biomedcentral.com/1753-6561/1/S1/S148
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The estimate of π0 was much lower, averaging 0.41 (Table
1). The plot of q-values against the corresponding p-values
showed nearly complete correspondence between these
measures (Fig. 1B). In addition, while the p-values appear
uniformly distributed above p = 0.10, the frequency at p ≤
0.05 is approximately 10-fold higher than baseline (Fig.
2B). Utilization of the Benjamini and Hochberg method
did not appreciably change the results (data not shown).
However, using a robust FDR method reduced the
number of significant results to 581 SNPs (27.7%).
In the SNPs flanking DR, average LD (r2) was 0.20, with
very little correlation between LD and the p-value of the
association (Spearman's r = -0.07, NS).
Conclusion
Genome-wide FDR reduced the number of results identi-
fied as significant compared with unadjusted p-value
thresholds (e.g., p  ≤ 0.05), and similar to Bonferroni
adjusted  p-value thresholds. Defining false positives as
greater than 5 cM from a causal locus, SNPs identified by
FDR exhibited only a 3.3% FP rate; thus, FDR was empir-
ically more conservative than expected in this analysis.
For fine-mapped regions, FDR and p-value methods all
produced a high proportion of significant results. This
breakdown in FDR in fine mapping may be due to the
extremely skewed distribution of p-values seen in the
region harboring disease-causing alleles. Pounds and
Cheng [4] have noted the importance of the distribution
of the p-values in FDR estimation. When FDR was esti-
mated using a robust methodology, there was a marked
reduction in the number of significant tests; however, a
large number of significant results remained. Likewise, the
low correlation between pair-wise LD and p-values sug-
gests that the large number of significant findings was not
due to LD. However, because the causative locus was
modeled as a tri-allelic marker, the pairwise LD between
bi-allelic SNPs may not capture the true extent of LD with
the DR locus.
We suspect that these findings were due to the very strong
association (p < 10-300) between the DR locus (a tri-allelic
marker) and RA. Because GAW15 Problem 3 was modeled
on results from RA analyses, it is possible that other dis-
eases may exhibit similarly strong associations that persist
over a large number of SNPs. This may be especially true
when causal variants are multi-allelic, such as the relation-
ship between Kringle repeat number in the apolipopro-
tein A gene and serum Lp(a) [5].
In summary, we have demonstrated that FDR, as imple-
mented in the program QVALUE, appears appropriate for
Histogram of p-values for all replicates combined Figure 2
Histogram of p-values for all replicates combined. A, 
Genome-wide (n = 9187 SNPs per replicate); B, fine mapped 
region (n = 2094 SNPs per replicate).
A
B
p-Values versus q-values for all replicates combined Figure 1
p-Values versus q-values for all replicates combined. 
A, Genome-wide; B, fine mapped region.
A BPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Proceedings 2007, 1(Suppl 1):S148 http://www.biomedcentral.com/1753-6561/1/S1/S148
Page 4 of 4
(page number not for citation purposes)
genome-wide association studies where the majority of
tests will not be significant. However, caution should be
employed when using it for fine mapping because these
regions may contain a large number of highly significant
associations. This biased distribution appears to poorly
affect FDR performance. In circumstances in which a large
number of significant results are identified, other
approaches should be considered to control error rate
such as the double trend test [6] or the use of haplotypes
[7].
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Table 1: Results from FDR program QVALUE in 11 replicates
Genome-wide (n = 9187 SNPs) Fine mapping (n = 2094 SNPs)
Number significant (%) Number significant (%)
Replicate p ≤ 0.05 Bonferroni FDR FDR π0 p ≤ 0.05 Bonferroni FDR FDR π0
90 498 (5.4) 21 (0.23) 28 (0.30) 0.982 944 (45.1) 489 (23.4) 1001 (47.8) 0.339
91 483 (5.3) 21 (0.23) 28 (0.30) 0.997 948 (45.3) 448 (21.4) 940 (44.9) 0.464
92 484 (5.3) 23 (0.25) 24 (0.26) 1 939 (44.9) 459 (21.9) 1082 (51.7) 0.248
93 501 (5.5) 18 (0.20) 25 (0.27) 1 914 (43.7) 435 (20.8) 910 (43.5) 0.468
94 526 (5.7) 19 (0.21) 23 (0.25) 0.989 899 (43.0) 444 (21.2) 879 (42.0) 0.471
95 493 (5.4) 20 (0.22) 26 (0.28) 0.992 1010 (48.3) 432 (20.6) 1069 (51.1) 0.355
96 494 (5.4) 18 (0.20) 26 (0.28) 1 945 (45.2) 463 (22.1) 966 (46.1) 0.411
97 533 (5.8) 17 (0.19) 22 (0.24) 0.992 1000 (47.8) 443 (21.2) 1010 (48.2) 0.439
98 500 (5.4) 19 (0.21) 22 (0.24) 0.958 939 (44.9) 437 (20.9) 926 (44.2) 0.467
99 501 (5.5) 21 (0.23) 26 (0.28) 1 923 (44.1) 459 (21.9) 915 (43.7) 0.486
100 528 (5.8) 20 (0.22) 22 (0.24) 0.988 955 (45.6) 428 (20.4) 981 (46.8) 0.366
Average 503.7 (5.5) 19.7 (0.21) 24.7 (0.27) 0.991 946.9 (45.2) 448.8 (21.4) 970.8 (46.4) 0.410